Home >
Medicine Info >
Taficita Tablet
Loading interface...

Taficita Tablet

Manufactured byMylan Pharmaceuticals
ContainsTenofovir (25 mg) + Emtricitabine (200 mg)
Description
Taficita Tablet is an antiviral medicine that consists of Tenofovir and Emtricitabine. It is used for the treatment of human immunodeficiency virus (HIV) infection (a condition that occurs when the virus attacks the immune system and interferes with your body's ability to fight infections or diseases). Taficita Tablet will not cure HIV infection, but it may delay the progression of a chronic, potentially life-threatening condition known as acquired immunodeficiency syndrome (AIDS) and other HIV-related conditions. This medicine works by preventing the virus from multiplying. Taficita Tablet has some side effects like nausea, vomiting, stomach pain, diarrhoea, headache, confusion, dizziness, trouble sleeping, abnormal dreams, etc. Most of them are temporary and resolve with time. Consult your doctor if these side effects are getting persistent or worse. Avoid driving vehicles and operating machines while taking this medicine as it can blur your vision or make you feel dizzy. Taficita Tablet is usually taken on an empty stomach, one hour before or two hours after a meal. Your dose and duration of therapy will be dependent on the severity of your condition. Take this medicine same time every day to maintain a constant level of medicine in your body. Do not stop taking this medicine without consulting with your doctor as your symptoms could come back. Taficita Tablet is not recommended in children below the age of 12 years with a body weight below 35 kg and if you are allergic to it. Inform your doctor about your pre-existing medical conditions and current medications. This can help your doctor to adjust your dose to avoid side effects. If you are pregnant or breastfeeding, consult your doctor before taking medicine.
QUICK LINKS:
Side effectsConcernsUsage

Side effects

Major & minor side effects for Taficita Tablet

  • Nausea and vomiting
  • Diarrhoea
  • Dizziness
  • Headache
  • Stomach pain
  • Depression
  • Rash
  • Confusion
  • Drowsiness
  • Abnormal dreams
  • Trouble sleeping

Uses of Taficita Tablet

What is it prescribed for?

  • HIV infection
Read More
Concerns

Commonly asked questions

  • How long does it take for this medicine to take effect?
    The time required for Taficita Tablet to show its effect is not clinically established.
  • How long do the effects of this medicine last?
    The time duration fwhich Taficita Tablet remains active in your body is not clinically established.
  • Is it safe to consume alcohol while taking this medicine?
    Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.
  • Is this a habit forming medicine?
    No habit-forming tendency has been reported for Taficita Tablet.
  • Can this medicine be taken during pregnancy?
    Taficita Tablet is not recommended for use in pregnant women as not enough studies are done to understand its safety in such conditions.
  • Can this medicine be taken while breast-feeding?
    Due to the lack of safety information, Taficita Tablet is not recommended for use while breastfeeding.

Allergy

Avoid taking Taficita Tablet if you are allergic to it. Serious allergic reactions to this medicine are rare. However, seek immediate medical attention if you notice any symptoms such as skin rash, itching/swelling (especially of the face/tongue/throat), severe dizziness, breathing difficulty, etc.

Severe liver disease

Taficita Tablet is not recommended for use if you have severe liver problems, as this medicine may cause liver toxicity and further worsen your condition.

Voriconazole

Voriconazole is an antifungal medicine used to treat fungal infections. Voriconazole may increase the blood concentration of Taficita Tablet, which may increase the risk of frequent and severe side effects. Hence, combined use of Taficita Tablet and Voriconazole is not recommended.

Elbasvir/Grazoprevir

Elbasvir/Grazoprevir are antiviral medicines used in the treatment of hepatitis C (a viral infection that causes swelling of the liver). Taficita Tablet may decrease the blood concentration of Elbasvir/Grazoprevir, resulting in the loss of its therapeutic effect. Hence, the combined use of Taficita Tablet and Elbasvir/Grazoprevir is not recommended.
Warnings for special population

Pregnancy

Taficita Tablet is not recommended for use in pregnant women as not enough studies are done to understand its safety in such conditions.

Breast-feeding

Due to the lack of safety information, Taficita Tablet is not recommended for use while breastfeeding.
General warnings

Immune reconstitution syndrome

Changes in your immune system can occur when you start taking Taficita Tablet. Your immune system may get stronger and begin to fight infections that have been hidden in your body for a long time. It may cause an exaggerated response making the symptoms of infection worse. Inform your doctor if you develop any new symptoms after starting treatment with Taficita Tablet.

Fat redistribution

Taficita Tablet should be used with caution as it may cause redistribution or accumulation of body fat. It may result in central obesity, buffalo hump (excess fat behind the neck), peripheral wasting (difficulty in moving an arm or leg or making any movement), facial wasting (fat loss in the cheeks and temples), breast enlargement, and cushingoid appearance (extra fat build up on the sides of the face and weight gain). Consult your doctor if you have any concerns.

Lactic acidosis

Lactic acidosis is a build-up of lactic acid in the bloodstream. Taficita Tablet should be used with caution due to the increased risk of lactic acidosis. Report any unusual symptoms like muscle cramps, unusual weakness or tiredness, feeling dizzy or lightheaded, fast or abnormal heartbeat, etc., to your doctor immediately.

Decreased bone mineral density

Taficita Tablet should be used with caution as it may cause a decrease in bone mineral density (amount of bone mineral in your bones).

Driving or operating machines

Taficita Tablet may cause dizziness, drowsiness, and impaired concentration. Hence, avoid performing activities that require mental alertness such as driving vehicles or operating machines if you experience such symptoms.

Missed Dose

Take the missed dose of Taficita Tablet as soon as you remember. Skip the missed dose if it is time for your next scheduled dose. Do not use extra medicine to make up for the missed dose.

Overdose

Never take more than the prescribed dose of Taficita Tablet. Seek emergency medical treatment in case of an overdose for further guidance.
All drugs interact differently for person to person. You should check all the possible interactions with your doctor before starting any medicine.
Interaction with Alcohol

Description

Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.

Instructions

Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.
Interaction with Medicine

Citalopram

Fluconazole

Amiodarone

Ciprofloxacin

Azithromycin

Disease interactions

Increase in cholesterol levels

Taficita Tablet should be used with caution as it may cause an increase in cholesterol and triglycerides (a type of fat) levels in the body. Your doctor may suggest blood tests for periodic monitoring of your cholesterol and triglycerides levels while you are taking this medicine.

CNS disorders

Taficita Tablet may cause depression, aggressive behaviour, confusion, suicidal thoughts, etc. Hence this medicine should be used with extreme caution if you have a history of mental problems due to the increased risk of worsening your condition. Inform your doctor if you notice any change in mood and behaviour or develop thoughts of self-harm.

Kidney Disease

Taficita Tablet should be used with caution if you have kidney problems as this medicine may further worsen your condition. Your doctor may adjust the dose based on your clinical condition.

QT Prolongation

QT prolongation is a condition in which your heart muscles take a longer time to recharge between a heartbeat. Taficita Tablet should be used with caution as it may cause QT prolongation. It is not recommended for use if you have any clinical condition or taking any medication known to cause QT prolongation.
Food interactions
Information not available.
Lab interactions
Information not available.
This is not an exhaustive list of possible drug interactions. You should consult your doctor about all the possible interactions of the drugs you’re taking.
Take Taficita Tablet as instructed by your doctor. Do not take in larger or smaller quantities than recommended. Avoid the discontinuation of this medicine without consulting your doctor, as it can worsen your condition. Inform your doctor immediately if you experience any change in mood or behaviour or develop suicidal thoughts. Your doctor may suggest tests to monitor your liver function and lipid (fats) levels during treatment with this medicine. Avoid driving vehicles or operating machines, as this medicine can make you feel dizzy or drowsy. This medicine may cause redistribution and accumulation of body fat in different parts of your body, such as below your neck, upper back, breasts, or around the stomach. It may also cause loss of body fat from your legs, arms, and face. Consult your doctor if you have any concerns.
Miscelleneous

To be taken on an empty stomach

To be taken as instructed by doctor

Causes sleepiness

How it works
Taficita Tablet works by stopping the human immunodeficiency virus (HIV) from multiplying.
Legal Status

Approved

Approved

Approved

Approved

Classification

Category

Antiviral combinations

Schedule

Schedule H

Drugs, H., 2021. Efavirenz: MedlinePlus Drug Information. [online] Medlineplus.gov. Available at: [Accessed 23 November 2021].

https://medlineplus.gov/druginfo/meds/a699004.html

Dailymed.nlm.nih.gov. 2021. DailyMed - SUSTIVA- efavirenz capsule, gelatin coatedSUSTIVA- efavirenz capsule, gelatin coatedSUSTIVA- efavirenz tablet, film coated. [online] Available at: < [Accessed 23 November 2021].

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=32d6371e-ba56-4294-b732-6d43627c5c47>

Gilead.com. 2022. [online] Available at: < [Accessed 5 April 2022].

https://www.gilead.com/-/media/55b14ac03ef94b6f98d5d3c31ea0137b.ashx>

Medicines.org.uk. 2022. Descovy 200 mg/25 mg film coated tablets - Summary of Product Characteristics (SmPC) - (emc). [online] Available at: < [Accessed 5 April 2022].

https://www.medicines.org.uk/emc/product/2108/smpc>

Ema.europa.eu. 2022. [online] Available at: < [Accessed 5 April 2022].

https://www.ema.europa.eu/en/documents/product-information/descovy-epar-product-information_en.pdf>

Rad-ar.or.jp. 2022. Search results detail| Kusurino-Shiori(Drug information Sheet). [online] Available at: < [Accessed 5 April 2022].

https://www.rad-ar.or.jp/siori/english/kekka.cgi?n=40977>
Loading related questions...
Something doesn’t feel right?
Report an error

Information on this page was last updated on 11 Jan 2023

Disclaimer

We’ve made all possible efforts to ensure that the information provided here is accurate, up-to-date and complete, however, it should not be treated as a substitute for professional medical advice, diagnosis or treatment. Practo only provides reference source for common information on medicines and does not guarantee its accuracy or exhaustiveness. The absence of a warning for any drug or combination thereof, should not be assumed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Practo does not assume any responsibility for any aspect of healthcare administered with the aid of information provided above. If you have any doubts about your medication then we strongly recommend that you consult with your doctor, nurse or healthcare provider. See detailed T&C here.